99 related articles for article (PubMed ID: 7545352)
1. Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study.
Thiele J; Kvasnicka HM; Niederle N; Kloke O; Schmidt M; Lienhard H; Zirbes T; Meuter RB; Leder LD; Fischer R
Am J Hematol; 1995 Sep; 50(1):30-9. PubMed ID: 7545352
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zirbes TK; Birnbaum F; Kressmann C; Melguizo-Grahmann M; Frackenpohl H; Sprungmann C; Leder LD; Diehl V; Zankovich R; Schaefer HE; Niederle N; Fischer R
Leuk Lymphoma; 2000 Jan; 36(3-4):295-308. PubMed ID: 10674901
[TBL] [Abstract][Full Text] [Related]
3. Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow.
Thiele J; Kvasnicka HM; Titius BR; Parpert U; Nebel R; Zankovich R; Dienemann D; Stein H; Diehl V; Fischer R
Ann Hematol; 1993 Jun; 66(6):291-302. PubMed ID: 8318559
[TBL] [Abstract][Full Text] [Related]
4. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Niederle N; Zirbes TK; Schmidt M; Dammasch J; Meuter BR; Leder LD; Kloke O; Diehl V
Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
[TBL] [Abstract][Full Text] [Related]
5. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Schaefer HE
Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
[TBL] [Abstract][Full Text] [Related]
6. Erythropoiesis in CML--immunomorphometric quantification, PCNA-reactivity, and influence on survival.
Thiele J; Hoefer M; Kvasnicka HM; Bertsch HP; Zankovich R; Fischer R
Hematol Pathol; 1993; 7(4):239-49. PubMed ID: 7906686
[TBL] [Abstract][Full Text] [Related]
7. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Leder LD; Schaefer HE
Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patients.
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Diehl V; Zankovich R; Niederle N; Leder LD; Schaefer HE
Br J Haematol; 2001 Mar; 112(3):727-39. PubMed ID: 11260078
[TBL] [Abstract][Full Text] [Related]
9. A histomorphometric analysis of trephine biopsies of bone marrow from 65 patients with chronic myeloid leukemia. Classification of patients into subgroups with different survival patterns.
Thiele J; Wienhold S; Zankovich R; Fischer R
Anal Quant Cytol Histol; 1990 Apr; 12(2):103-16. PubMed ID: 2350386
[TBL] [Abstract][Full Text] [Related]
10. Effects of interferon treatment on the macrophage population in the bone marrow of patients with Ph1+-CML.
Thiele J; Kvasnicka HM; Zirbes TK; Baldus SE; Djuren O; Lienhard H; Lorenzen J; Leder LD; Niederle N; Fischer R
Hematopathol Mol Hematol; 1996; 10(4):201-12. PubMed ID: 9042663
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
Thiele J; Zirbes TK; Lorenzen J; Kvasnicka HM; Dresbach S; Manich B; Leder LD; Niederle N; Diehl V; Fischer R
J Pathol; 1997 Mar; 181(3):316-22. PubMed ID: 9155719
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow histopathology in chronic myelogenous leukemia (CML)--evaluation of distinctive features with clinical impact.
Thiele J; Kvasnicka HM; Fischer R
Histol Histopathol; 1999 Oct; 14(4):1241-56. PubMed ID: 10506940
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation.
Thiele J; Kvasnicka HM; Beelen DW; Pilgram B; Rose A; Leder LD; Schaefer UW
Leukemia; 2000 Aug; 14(8):1378-85. PubMed ID: 10942232
[TBL] [Abstract][Full Text] [Related]
14. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
Thiele J; Zirbes T; Kvasnicka HM; Niederle N; Dammasch J; Schmidt M; Windecker R; Leder LD; Diehl V; Fischer R
Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
[TBL] [Abstract][Full Text] [Related]
15. Histo- and immunomorphometry of megakaryopoiesis in chronic myeloid leukemia with myelofibrosis and so-called primary (idiopathic) osteo-myelofibrosis/-sclerosis.
Thiele J; Steinberg T; Hoeppner B; Wienhold S; Wagner S; Dienemann D; Fischer R
Anal Cell Pathol; 1990 Jul; 2(4):215-27. PubMed ID: 2275869
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow engraftment: histopathology of hematopoietic reconstitution following allogeneic transplantation in CML patients.
Thiele J; Kvasnicka HM; Beelen DW; Leder LD; Schaefer UW
Histol Histopathol; 2001 Jan; 16(1):213-26. PubMed ID: 11193198
[TBL] [Abstract][Full Text] [Related]
17. Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia.
Wilhelm M; Bueso-Ramos C; O'Brien S; Pierce S; Keating M; Talpaz M; Kantarjian HM
Leukemia; 1998 Jan; 12(1):65-70. PubMed ID: 9436922
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the histomorphometric features of bone marrow trephine biopsies in patients with chronic myeloid leukemia.
Lamba A; Dey P; Kumari S; Marwaha N
Anal Quant Cytol Histol; 2007 Dec; 29(6):370-6. PubMed ID: 18225393
[TBL] [Abstract][Full Text] [Related]
19. Effect of interferon therapy on bone marrow morphology in chronic myeloid leukemia: a cytochemical and immunohistochemical study of trephine biopsies.
Thiele J; Zirbes TK; Kvasnicka HM; Lorenzen J; Niederle N; Leder LD; Fischer R
J Interferon Cytokine Res; 1996 Mar; 16(3):217-24. PubMed ID: 8697144
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors and survival in chronic myeloproliferative disorders].
Kvasnicka HM; Thiele J; Schmitt-Graeff A; Schaefer HE
Pathologe; 2000 Jan; 21(1):63-72. PubMed ID: 10663670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
